Sterling Biotech Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 31, 2008, to consider Audited accounts for the year ending December 31, 2007 and also to consider the declaration of Dividend subject to the final approval of the members at the Annual General Meeting.
This entry was posted
on Monday, March 24th, 2008 at 6:49 am and is filed under Commodities.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
